A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV
NCT02495246
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL:
ChAd3-EBO-Z
BIOLOGICAL:
Ad26.ZEBOV
Sponsor
University of Oxford